Tag: biotech stocks
Biotech Sector (IBB): A Closer Look At The 2017 Rally
The Nasdaq Biotechnology ETF (NASDAQ:IBB) saw a knee-jerk reaction lower Wednesday after President-elect Donald Trump made harsh comments about drug pricing.
On Wednesday, it finished off by -2.99%.
While that...
Biotechnology Sector Testing Bull Market Trendline
When this market cycle finally comes to an end, among the sectors that will be remembered as one of its key drivers is biotechnology....
Gilead Sciences (GILD): Fundamentals vs Technicals
About $7 ago, I tweeted that Gilead Sciences stock (NASDAQ:GILD) was starting to present a real conundrum of fundamentals/valuation (positive) vs. technicals (negative). So...
Biotech Sector M&A Breakdown: Stocks To Watch
The Biotech Sector (NASDAQ:IBB) has been volatile the last few weeks, more so than the market at least with two opposing forces. On one...
Biotech Sector (IBB): Is The Rally Just Getting Started?
Are we really talking about a biotech sector breakout? Biotech stocks have been through a lot in the last 12 months...
The biotech sector as...
Biotechnology Index BTK Trading Near Critical Price Level
A key index of biotechnology stocks may be approaching significant levels of resistance.
Throughout the course of the post-February rally, one topic that has been...
5 Large Cap Biotech Stocks With Long-Term Upside
Here's a breathtaking fact: The IBB (Biotech Index) went down 33% from peak to trough during the "Great Recession." The IBB is now down...
Biotech Sector Fund ($XBI) Gets Back On Trend
When we last wrote about XBI, the S&P Biotech Sector Fund ETF, we noted that it appeared ready for a countertrend rally. In the...
Options Traders Look For Q2 Upside In Biotech Stocks
Biotech was a sector that was a notable laggard in Q1 with the Nasdaq Biotech Sector ETF (IBB) down nearly 24% and S&P Biotech...
Biotech Stocks Look Ripe For A Countertrend Rally
Over two weeks ago, we shared our thoughts on why the S&P Biotech Sector ETF (symbol XBI) might be nearing a tradable bottom. In...